Type II Alveolar Epithelial Cells Promote Sepsis‐Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release
Advanced Science · 2026
DOI: 10.1002/advs.202500376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chengxi Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Anesthesiology and Pain Research Institute, the Second Affiliated Hospital, University of South China, Hengyang, Hunan,…. Hauptthemen laut MEDLINE: Sepsis, Macrophages, Alveolar, RNA, Long Noncoding, Exosomes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Science and Technology Innovation Program of Hunan Province, The Health Research Project of Hunan Provincial Health Commission.
Themen: Sepsis
Abstract (Originalsprache)
Secondary pneumonia, a common complication of sepsis‐induced immunosuppression (SII), is closely linked to alveolar macrophage (AM) dysfunction primarily due to impaired glycolytic activity. However, the underlying molecular mechanisms remain unclear. In this study, it is found that exosomal RNA component of the mitochondrial RNA processing endoribonuclease (Rmrp), derived from type II alveolar epithelial cells (AEC‐IIs), drives glycolytic defects and immune tolerance in AMs following cecal ligation and puncture (CLP) sepsis. Targeted depletion of Rmrp in either AEC‐IIs or AMs alleviated SII and secondary pneumonia induced by Pseudomonas aeruginosa infection 48 h post CLP. Mechanistically, Rmrp interacts with and inhibits the ubiquitination and degradation of the RNA‐binding protein zinc finger protein 36 (ZFP36). This results in ZFP36 upregulation, subsequently accelerating the decay of 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase 3 (Pfkfb3 ) mRNA by binding to its AU‐rich elements in the 3′ untranslated region. The degradation of Pfkfb3 mRNA leads to impaired glycolysis and suppresses immune responses in AMs after sepsis. Additionally, it is found that exosomal Rmrp levels are correlated with AM immune tolerance and the prognosis of patients with sepsis. These findings highlight the critical role of AEC‐II‐derived exosomal Rmrp in the pathogenesis of SII and secondary pneumonia. Importantly, the study suggests that exosomal Rmrp may serve as a biomarker for predicting and managing SII in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Anesthesiology and Pain Research Institute, the Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China.
- Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
- Department of Pain Medicine, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523000, China.
- Biosafety Level 3 Laboratory, Hunan Province Center for Disease Control and Prevention, Changsha, Hunan, 410005, China.
- Institute of Human Virology, Zhongshan School of Medicine, and Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.
- Pulmonary and Critical Care Medicine, the Second Affiliated Hospital, University of South China. Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
ORCID-Profile: Xu Wu
Förderung
- National Natural Science Foundation of China
- The Science and Technology Innovation Program of Hunan Province
- The Health Research Project of Hunan Provincial Health Commission
- The Key R&D Program of Hunan Provincial Natural Science Funds
- Hunan Clinical Research Center for Acute and Chronic Pain
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Liu, C., Xuan, W., Cao, S., Jia, H., Wu, Q., Tan, X., Wang, Q., Li, X., Ding, L., Xiong, Y., Zhao, M., Zheng, L., Xi, Y., Tan, J., Li, R., Zhang, X., Liu, W., & Wu, X. (2026). Type II Alveolar Epithelial Cells Promote Sepsis‐Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release. Advanced Science. https://doi.org/10.1002/advs.202500376
Vancouver
Liu C, Xuan W, Cao S, Jia H, Wu Q, Tan X, et al. Type II Alveolar Epithelial Cells Promote Sepsis‐Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release. Advanced Science. 2026. doi:10.1002/advs.202500376
BibTeX
@article{Liu2026,
author = {Liu, Chengxi and Xuan, Weixia and Cao, Song and Jia, Huayun and Wu, Qian and Tan, Xiaowu and Wang, Qijie and Li, Xiaojun and Ding, Lisha and Xiong, Yaru and Zhao, Meiyun and Zheng, Longcheng and Xi, Yunzhu and Tan, Jianhua and Li, Rong and Zhang, Xulong and Liu, Wenjie and Wu, Xu},
title = {Type II Alveolar Epithelial Cells Promote Sepsis‐Induced Immunosuppression in Alveolar Macrophages via Exosomal lncRNA Rmrp Release},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202500376}
}
EUVIMED